{"id":"low-dose-atropine-eye-drops","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Dry mouth"},{"rate":"5-10%","effect":"Blurred vision"},{"rate":"5-10%","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Atropine is an anticholinergic medication that blocks the action of acetylcholine, a neurotransmitter that causes the muscles in the eye to contract. By blocking this action, atropine causes the pupils to dilate, which reduces the pressure in the eye and can help to treat conditions such as uveitis and glaucoma.","oneSentence":"Atropine eye drops work by dilating the pupils to reduce the pressure in the eye.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:19:33.134Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of uveitis"},{"name":"Treatment of glaucoma"}]},"trialDetails":[{"nctId":"NCT06450132","phase":"PHASE4","title":"Changes in Eye Shape With Myopia Management Interventions","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ohio State University","startDate":"2024-08-01","conditions":"Myopia","enrollment":75},{"nctId":"NCT07329777","phase":"PHASE3","title":"Atropine in the Treatment of Myopia Study in Malaysia","status":"RECRUITING","sponsor":"IDB VisionCare SDN BHD","startDate":"2025-09-17","conditions":"Myopia Progression","enrollment":144},{"nctId":"NCT06209281","phase":"PHASE3","title":"A Phase III Clinical Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops","status":"ACTIVE_NOT_RECRUITING","sponsor":"Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.","startDate":"2022-05-13","conditions":"Myopia","enrollment":526},{"nctId":"NCT06209320","phase":"PHASE3","title":"A Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops","status":"ACTIVE_NOT_RECRUITING","sponsor":"Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.","startDate":"2022-03-15","conditions":"Myopia","enrollment":777},{"nctId":"NCT03911271","phase":"PHASE2","title":"Low-dose Atropine for the Prevention of Myopia Progression in Danish Children","status":"COMPLETED","sponsor":"Line Kessel","startDate":"2019-05-30","conditions":"Myopia","enrollment":97},{"nctId":"NCT05667454","phase":"PHASE3","title":"MAD Trial: Myopia Atropine Dose","status":"RECRUITING","sponsor":"Erasmus Medical Center","startDate":"2022-12-19","conditions":"Progressive Myopia","enrollment":550},{"nctId":"NCT03865160","phase":"PHASE2, PHASE3","title":"Low-dose Atropine for Myopia Control in Children","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Eye Hospital, Freiburg","startDate":"2021-10-19","conditions":"Myopia, Progressive","enrollment":302},{"nctId":"NCT06708156","phase":"PHASE3","title":"The Effectiveness and Safety of Two Low-concentration Atropine Sulfate Eye Drops (0.01%/0.02%) for Delaying the Pediatric Myopia Progression","status":"RECRUITING","sponsor":"Oupushifang Pharmaceutical Technology Co., Ltd.","startDate":"2024-06-15","conditions":"Myopia, Myopia Progression","enrollment":606},{"nctId":"NCT06727019","phase":"NA","title":"Daily Low-level Red Light and 0.01% Low-dose Atropine for Myopia Prevention","status":"COMPLETED","sponsor":"Beijing Tongren Hospital","startDate":"2023-04-10","conditions":"Myopia","enrollment":138},{"nctId":"NCT06265454","phase":"PHASE2","title":"Low Dose Atropine Eye Drops in Myopic Egyptian Children","status":"NOT_YET_RECRUITING","sponsor":"Ain Shams University","startDate":"2024-09-01","conditions":"Myopia Progression, Axial Length, Eye, Sclera Thickness","enrollment":75},{"nctId":"NCT06174935","phase":"PHASE2","title":"Low Dose Atropine for Symptomatic Vitreous Floaters","status":"UNKNOWN","sponsor":"Jeanette Du","startDate":"2024-01-01","conditions":"Vitreous Floaters","enrollment":200},{"nctId":"NCT03690089","phase":"PHASE2","title":"Low-dose Atropine Eye Drops to Reduce Progression of Myopia in Children in the United Kingdom","status":"ACTIVE_NOT_RECRUITING","sponsor":"Belfast Health and Social Care Trust","startDate":"2019-04-03","conditions":"Myopia","enrollment":289},{"nctId":"NCT03334253","phase":"PHASE3","title":"Low-Dose Atropine for Treatment of Myopia","status":"COMPLETED","sponsor":"Jaeb Center for Health Research","startDate":"2018-06-01","conditions":"Myopia","enrollment":200},{"nctId":"NCT04290039","phase":"PHASE1","title":"Sublingual vs IV Atropine Bioavailability Study","status":"COMPLETED","sponsor":"Biomedical Advanced Research and Development Authority","startDate":"2020-01-04","conditions":"Toxic Effect of Organophosphate and Carbamate Insecticides","enrollment":15},{"nctId":"NCT05683535","phase":"","title":"Adverse Events Related to Low Dose Atropine","status":"COMPLETED","sponsor":"Scripps Health","startDate":"2018-06-19","conditions":"Myopia, Progressive","enrollment":148},{"nctId":"NCT05803863","phase":"PHASE4","title":"Efficacy Comparison of 2 Low-dose Atropine Eye Drops in Vietnamese Children Myopia Management","status":"UNKNOWN","sponsor":"University of Medicine and Pharmacy at Ho Chi Minh City","startDate":"2023-04-15","conditions":"Myopia","enrollment":108},{"nctId":"NCT05372991","phase":"PHASE1, PHASE2","title":"Safety, Tolerability and Pharmacodynamics Evaluation of CBT-009 Eye Drop","status":"COMPLETED","sponsor":"Cloudbreak Therapeutics, LLC","startDate":"2022-07-20","conditions":"Myopia, Progressive","enrollment":84},{"nctId":"NCT04807361","phase":"","title":"Assessment of Accommodation Behavior in Children Under Myopia Control Treatment (Pilot Study)","status":"COMPLETED","sponsor":"State University of New York College of Optometry","startDate":"2020-12-01","conditions":"Accomodation, Biofeedback Training, Myopia","enrollment":44},{"nctId":"NCT05478356","phase":"NA","title":"The Effects of Low-dose Atropine and Orthokeratology in Pediatric Myopia Control","status":"UNKNOWN","sponsor":"Evidence Based Cataract Study Group","startDate":"2022-08-01","conditions":"Myopia","enrollment":100},{"nctId":"NCT02870478","phase":"PHASE3","title":"The Effects of Low Concentration Atropine on Pupil Size and Accommodation","status":"COMPLETED","sponsor":"University of California, Berkeley","startDate":"2016-07","conditions":"Myopia","enrollment":32},{"nctId":"NCT04338373","phase":"PHASE3","title":"Effectiveness of 0.01% Atropine Sulfate Solution in Controlling of Myopia Progression in Children","status":"UNKNOWN","sponsor":"The V.P. Vyhodcev Eye Hospital","startDate":"2020-02-17","conditions":"Myopia","enrollment":70},{"nctId":"NCT03544827","phase":"PHASE4","title":"The Effects of Low Dose Atropine on Choroidal Thickness","status":"COMPLETED","sponsor":"State University of New York College of Optometry","startDate":"2018-05-21","conditions":"Myopia","enrollment":36}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":21,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Low dose atropine sulfate","Eye drops"],"phase":"phase_3","status":"active","brandName":"low dose atropine eye drops","genericName":"low dose atropine eye drops","companyName":"Ain Shams University","companyId":"ain-shams-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Atropine eye drops work by dilating the pupils to reduce the pressure in the eye. Used for Treatment of uveitis, Treatment of glaucoma.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}